1356089-38-7

Basic information

• Product Name: (E)-2-(4-(2-cyanovinylsulfonyl)phenyl)- 2-methylpropanoic acid
• Synonyms: (E)-2-(4-(2-cyanovinylsulfonyl)phenyl)- 2-methylpropanoic acid
• CAS NO: 1356089-38-7
• Molecular Formula: C₁₃H₁₃NO₄S
• Molecular Weight: 279.31162
• Mol File: 1356089-38-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (E)-2-(4-(2-cyanovinylsulfonyl)phenyl)- 2-methylpropanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-2-(4-(2-cyanovinylsulfonyl)phenyl)- 2-methylpropanoic acid(1356089-38-7)
• EPA Substance Registry System: (E)-2-(4-(2-cyanovinylsulfonyl)phenyl)- 2-methylpropanoic acid(1356089-38-7)

Safety Data

• Hazardous Substances Data: 1356089-38-7(Hazardous Substances Data)

Usage

General Description

(E)-2-(4-(2-cyanovinylsulfonyl)phenyl)-2-methylpropanoic acid, also known as BAY 11-7082, is a chemical compound that belongs to the class of organic compounds known as phenylpropanoic acids. It is a synthetic inhibitor of nuclear factor kappa B (NF-κB) activation and has potential anti-inflammatory and anti-cancer properties. (E)-2-(4-(2-cyanovinylsulfonyl)phenyl)- 2-methylpropanoic acid has been studied for its ability to suppress the expression of inflammatory cytokines and chemokines, as well as for its potential in the treatment of various diseases including cancer, autoimmune and inflammatory disorders. Its unique structure, with a cyanovinylsulfonyl group attached to a phenyl ring, makes it an interesting candidate for drug development and research in the fields of immunology and inflammation.

Upstream product

• 920-37-6 2-Chloroacrylonitrile 
• 32454-35-6 2-(4-bromophenyl)-2-methylpropionic acid 
• 871-29-4 trans-β-chloroacrylonitrile 

Downstream Products

• 1365091-30-0 (E)-3-[4-(1,1-dimethyl-2-oxo-2-piperidin-1-yl-ethyl)benzenesulfonyl]acrylonitrile 
• 1365091-29-7 (E)-3-[4-(1,1-dimethyl-2-morpholin-4-yl-2-oxo-ethyl)benzenesulfonyl]acrylonitrile 
• 1365091-28-6 (E)-3-{4-[1,1-dimethyl-2-(4-methyl-piperazin-1-yl)-2-oxo-ethyl]-benzenesulfonyl}acrylonitrile 
• 1365091-35-5 2-[4-((E)-2-cyano-ethenesulfonyl)phenyl]-N-pyridin-2-ylmethylisobutyramide 
• 1365091-32-2 2-[4-((E)-2-cyano-ethenesulfonyl)phenyl]-N-isobutylisobutyramide 
• 1365091-33-3 2-[4-((E)-2-cyano-ethenesulfonyl)phenyl]-N-(3-methoxy-phenyl)isobutyramide 
• 1365091-31-1 N-(4-chloro-benzyl)-2-[4-((E)-2-cyano-ethenesulfonyl)phenyl]isobutyramide 
• 1365091-27-5 2-[4-((E)-2-cyano-ethenesulfonyl)phenyl]-N-phenylisobutyramide 
• 1365091-34-4 2-[4-((E)-2-cyano-ethenesulfonyl)phenyl]-N-prop-2-ynylisobutyramide 
• 1394819-12-5 2-[4-((E)-2-cyano-ethenesulfonyl)-phenyl]-N-(4-methoxy-phenyl)-isobutyramide 
• 1394818-98-4 N-benzyl-2-[4-((E)-2-cyanoethenesulfonyl)phenyl]isobutyramide 
• 1394819-08-9 (E)-3-{4-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-1,1-dimethyl-2-oxo-ethyl]-benzenesulfonyl}-acrylonitrile 
• 1394819-06-7 2-[4-((E)-2-cyanoethenesulfonyl)phenyl]-N-((R)-1-phenylethyl)isobutyramide 
• 1394819-34-1 2-[4-((E)-2-cyano-ethenesulfonyl)-phenyl]-N-(2-methoxy-benzyl)-N-methyl-isobutyramide 

Relevant articles and documents

Design, synthesis, and biological evaluation of sulfonyl acrylonitriles as novel inhibitors of cancer metastasis and spread

The spread of intra-abdominal cancers is a vexing clinical problem for which there is no widely effective treatment. We discovered previously that (2E)-3-[(4-tert-butylphenyl)sulfonyl]acrylonitrile (1) induced cancer cell apoptosis during adhesion to normal mesothelial cells which line the peritoneum. We recently demonstrated that the sulfonylacrylonitrile portion of 1 and hydrophobic aryl substitution were essential for pro-apoptotic activity in cancer cells. Here we synthesized a diverse series of analogues of 1 in order to improve the efficacy and pharmaceutical properties. Analogues and 1 were compared in their ability to cause cancer cell death during adhesion to normal mesothelial cell monolayers. Potent analogues identified in the in vitro assay were validated and found to exhibit improved inhibition of intra-abdominal cancer in two clinically relevant murine models of ovarian and pancreatic cancer spread and metastasis, highlighting their potential clinical use as an adjunct to surgical resection of cancers.

Synthesis and biological evaluation of sulfonyl acrylonitriles as novel inhibitors to peritoneal carcinomatosis

The vast majority of cancer patients die from metastasis, the process by which cancer cells spread to secondary tissues through body fluids. Peritoneal carcinomatosis is a type of metastasis in which cancer cells gain access to the intra-abdominal cavity and then implant in the peritoneum, the thin tissue that lines the abdominal wall and internal organs. Unfortunately, peritoneal carcinomatosis can occur following surgical resection of intra-abdominal malignancies. We previously reported proapoptotic activity of (2E)-3-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-2-propenenitrile (BAY 11-7085, 1) on colon and pancreatic cancer cells during adhesion and demonstrated that this compound could significantly inhibit peritoneal carcinomatosis in mice. 1,2 In order to determine the chemical basis of the anti-metastatic properties of BAY 11-7085, a series of analogs were synthesized and evaluated for their ability to induce apoptosis in pancreatic and ovarian cancer cells during adhesion to mesothelial cells, which line the surface of the peritoneum. The co-culture assay results were validated using a murine peritoneal carcinomatosis model. These analogs may greatly benefit patients undergoing surgical resections of colorectal, pancreatic, and ovarian cancers depending on their tolerability.